2021
DOI: 10.1080/14779072.2021.1856657
|View full text |Cite
|
Sign up to set email alerts
|

Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 164 publications
0
10
0
Order By: Relevance
“…One of LR’s limitations is when multiple variables with correlations are included, serious deviation would be generated and lead to overfitting [ 5 ]. The predictors of ISR are of multiple correlation and interaction [ 11 ]. Patients with diabetes are associated with renal dysfunction, dyslipidemia, long lesion, and smaller vascular diameter [ 16 18 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One of LR’s limitations is when multiple variables with correlations are included, serious deviation would be generated and lead to overfitting [ 5 ]. The predictors of ISR are of multiple correlation and interaction [ 11 ]. Patients with diabetes are associated with renal dysfunction, dyslipidemia, long lesion, and smaller vascular diameter [ 16 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…15 ISR predictors were selected according to documentation, including patient age, male gender, smoking history, clinical presentation of acute coronary syndrome (ACS), diabetes, hypertension, dyslipidemia, chronic kidney disease (CKD) stage, number of stenotic vessels (>50% of luminal diameter by QCA), number of stenting vessels, minimum stent diameter, total stent length, left main artery stenting, bifurcation stenting (left main), and stenting in complex lesions (type B2 and C) [ 11 ]. The CKD stage is classified by calculating the estimated glomerular filtration rate using the Modification of Diet in Renal Disease Study equation [ 12 ].…”
Section: Methodsmentioning
confidence: 99%
“…In clinic therapy, the long-term dosing in early stage has low absolute bioavailability and undesirable side effects [3]. For serious pathology, percutaneous stent implantation is widely used to restore the blood flow [4], but subsequent in-stent thrombosis and in-stent restenosis become an unforeseen fatal risk [5,6]. Recently, nanodrug delivery system has receive considerable attentions as a noninvasive therapeutic platform for the most diseases because of the attractive performances in medicament improvement, such as solubilizing and stabilizing drug delivery, enhancing therapeutic bioavailability by the target drug delivery and the controllable drug release, and significantly reducing drug toxicity and side effects [7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…Coronary stents are deployed to treat this disease by reopening stenotic regions in arteries to restore blood flow. But after stent implantation, the rate of the in-stent restenosis (ISR) is high (20-30%) [1]. One of the reasons for this phenomenon is that stent implantation induces changes in local hemodynamic environment, and has an adverse effect on the physiological behaviors of endothelial cells and other biomacromolecules [1].…”
mentioning
confidence: 99%
“…But after stent implantation, the rate of the in-stent restenosis (ISR) is high (20-30%) [1]. One of the reasons for this phenomenon is that stent implantation induces changes in local hemodynamic environment, and has an adverse effect on the physiological behaviors of endothelial cells and other biomacromolecules [1]. Therefore, carrying out studies about blood flow environment after stent implantation is of vital importance.…”
mentioning
confidence: 99%